{"id":485617,"date":"2020-05-20T16:58:01","date_gmt":"2020-05-20T16:58:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=485617"},"modified":"2020-05-20T16:58:01","modified_gmt":"2020-05-20T16:58:01","slug":"warm-auoimmune-hemolytic-anemia-waiha-epidemiology-insights-3year-historical-and-11year-forecast-analysis","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/warm-auoimmune-hemolytic-anemia-waiha-epidemiology-insights-3year-historical-and-11year-forecast-analysis_485617.html","title":{"rendered":"Warm Auoimmune Hemolytic Anemia (wAIHA) Epidemiology Insights: 3-year historical and 11-year forecast analysis"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1589978733.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Warm Auoimmune Hemolytic Anemia (wAIHA) Epidemiology Insights: 3-year historical and 11-year forecast analysis\" src=\"https:\/\/www.abnewswire.com\/uploads\/1589978733.png\" alt=\"Warm Auoimmune Hemolytic Anemia (wAIHA) Epidemiology Insights: 3-year historical and 11-year forecast analysis\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Warm autoimmune hemolytic anaemia Epidemiology<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">In 2017, as per the estimates by DelveInsight, Warm Autoimmune Haemolytic Anemia had affected 82,045 people approximately in the 7MM.<\/div>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &lsquo;Warm Autoimmune Hemolytic Anemia (WAIHA)- Epidemiology Forecast to 2030&rsquo; report delivers an in-depth understanding of the disease, historical &amp; forecasted epidemiology of Warm Autoimmune Hemolytic Anemia.<\/p>\n<p style=\"text-align: justify;\"><strong>Geography Covered<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The United States<\/li>\n<li>EU5 (Germany, France, Italy, Spain and the United Kingdom)<\/li>\n<li>Japan<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Study Period<\/strong>: 2017-2028<\/p>\n<p style=\"text-align: justify;\"><strong>Warm autoimmune hemolytic anemia (wAIHA) <\/strong>is the most common form of autoimmune hemolytic anemia.<strong> Autoimmune Ahemolytic anemia<\/strong> (AIHA) is a rare acquired autoimmune disease, as a consequence of which the immune system attacks its red blood cells considering them foreign substances.<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/warm-auoimmune-hemolytic-anemia-waiha-epidemiology-insights?utm_source=pr&amp;utm_medium=ab-jl&amp;utm_campaign=vinita\">Click to know more about the report<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Warm autoimmune hemolytic anemia Epidemiology <\/strong><\/p>\n<p style=\"text-align: justify;\">In 2017, as per the estimates by DelveInsight, Warm Autoimmune Haemolytic Anemia had affected 82,045 people approximately in the 7MM.<\/p>\n<p style=\"text-align: justify;\">WAIHA affects 1 in 35,000 in North America. With a population of about 57 crores, WAIHA is a cause of distress to many living in that continent only, let alone worldwide.<\/p>\n<p style=\"text-align: justify;\">The Warm Autoimmune Hemolytic Anemia (wAIHA) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/674173f229b985275dc935caef3387c1.png\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\"><strong>wAIHA<\/strong> <strong>Epidemiology Segmentation <\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Total prevalent cases of wAIHA<\/li>\n<li>Total prevalent cases of wAIHA<\/li>\n<li>Type-specific prevalent cases of wAIHA<\/li>\n<li>Gender-specific prevalent cases of wAIHA<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/warm-auoimmune-hemolytic-anemia-waiha-epidemiology-insights?utm_source=pr&amp;utm_medium=ab-jl&amp;utm_campaign=vinita\">&nbsp;<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Report Key Highlights<\/strong><\/p>\n<p style=\"text-align: justify;\">&bull; 11 Year Forecast of Warm Autoimmune Hemolytic Anemia epidemiology<\/p>\n<p style=\"text-align: justify;\">&bull; 7MM Coverage<\/p>\n<p style=\"text-align: justify;\">&bull; Total prevalent cases of WAIHA<\/p>\n<p style=\"text-align: justify;\">&bull; Prevalent Cases according to segmentation: Total Prevalent Cases of AIHA, Diagnosed Prevalence of wAIHA, Type-specific Prevalence of wAIHA, Gender-specific Prevalence of wAIHA<\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/warm-auoimmune-hemolytic-anemia-waiha-epidemiology-insights\" target=\"_blank\"><strong>Request for sample pages&nbsp;<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of contents <\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>1 Key Insights<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>2 Executive Summary<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>3 SWOT Analysis<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>4 wAIHA Market Overview at a Glance<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>5 Disease Background and Overview<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>6 Epidemiology and Patient Population<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>7 Country Wise-Epidemiology of wAIHA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>8 Treatment and Management of wAIHA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>9 Case Study<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10 Patient Journey<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>11 Unmet Needs<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12 Appendix<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>13 DelveInsight Capabilities<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>14 Disclaimer<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/blog\/warm-autoimmune-hemolytic-anemia-market\/\">Visit to know more.<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About <\/strong><strong>DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for better growth in the market.<\/p>\n<p style=\"text-align: justify;\">Browse through our vast repository from <a rel=\"nofollow\" href=\"https:\/\/delveinsight.com\/report-store.php?utm_source=pr&amp;utm_medium=jewish&amp;utm_campaign=vinita\">here<\/a>.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57049.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Vinita Rakheja <br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=warm-auoimmune-hemolytic-anemia-waiha-epidemiology-insights-3year-historical-and-11year-forecast-analysis\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=warm-auoimmune-hemolytic-anemia-waiha-epidemiology-insights-3year-historical-and-11year-forecast-analysis\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Warm autoimmune hemolytic anaemia Epidemiology In 2017, as per the estimates by DelveInsight, Warm Autoimmune Haemolytic Anemia had affected 82,045 people approximately in the 7MM. DelveInsight&rsquo;s &lsquo;Warm Autoimmune Hemolytic Anemia (WAIHA)- Epidemiology Forecast to 2030&rsquo; report delivers an in-depth understanding &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/warm-auoimmune-hemolytic-anemia-waiha-epidemiology-insights-3year-historical-and-11year-forecast-analysis_485617.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,423,404],"tags":[],"class_list":["post-485617","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Professional-Services","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/485617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=485617"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/485617\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=485617"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=485617"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=485617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}